Need help finding what you are looking for?
Contact Us
PUBLISHER: TechNavio | PRODUCT CODE: 1446176
PUBLISHER: TechNavio | PRODUCT CODE: 1446176
Global Neurological Biomarkers Market 2024-2028
PUBLISHED:
PAGES: 175 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The neurological biomarkers market is forecasted to grow by USD 7.82 bn during 2023-2028, accelerating at a CAGR of 13.01% during the forecast period. The report on the neurological biomarkers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of neurological disorders, growth in clinical trials for neurological disease-specific biomarkers, and increasing initiatives and support from governments to improve neurological healthcare access.
Technavio's neurological biomarkers market is segmented as below:
| Market Scope | |
|---|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 12.2% |
| CAGR | 13.01% |
| Incremental Value | $7.82bn |
By End-user
- Hospitals
- Clinical diagnostic centers
- Research organizations and others
By Indication
- AD
- PD
- ASD
- MS
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing focus on accurate neurological diagnostics as one of the prime reasons driving the neurological biomarkers market growth during the next few years. Also, growing availability of blood-based biomarkers and evolution of manual miRNA will lead to sizable demand in the market.
The report on the neurological biomarkers market covers the following areas:
- Neurological biomarkers market sizing
- Neurological biomarkers market forecast
- Neurological biomarkers market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurological biomarkers market vendors that include Abbott Laboratories, ACROBIOSYSTEMS INC., Advanced Brain Monitoring Inc., Alseres Pharmaceuticals Inc, Bio Rad Laboratories Inc., bioMerieux SA, Charles River Laboratories International Inc., EATRIS ERIC, Eli Lilly and Co., Enzo Biochem Inc., F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., IQVIA Holdings Inc., Merck KGaA, Metabolon Inc., PerkinElmer Inc, Proteome Sciences plc, QIAGEN NV, Quanterix Corp., and Thermo Fisher Scientific Inc.. Also, the neurological biomarkers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Product Code: IRTNTR73380
Table of Contents
1 Executive Summary
- 1.1 Market overview
2 Market Landscape
- 2.1 Market ecosystem
3 Market Sizing
- 3.1 Market definition
- 3.2 Market segment analysis
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
4 Historic Market Size
- 4.1 Global neurological biomarkers market 2018 - 2022
- 4.2 End-user Segment Analysis 2018 - 2022
- 4.3 Indication Segment Analysis 2018 - 2022
- 4.4 Geography Segment Analysis 2018 - 2022
- 4.5 Country Segment Analysis 2018 - 2022
5 Five Forces Analysis
- 5.1 Five forces summary
- 5.2 Bargaining power of buyers
- 5.3 Bargaining power of suppliers
- 5.4 Threat of new entrants
- 5.5 Threat of substitutes
- 5.6 Threat of rivalry
- 5.7 Market condition
6 Market Segmentation by End-user
- 6.1 Market segments
- 6.2 Comparison by End-user
- 6.3 Hospitals - Market size and forecast 2023-2028
- 6.4 Clinical diagnostic centers - Market size and forecast 2023-2028
- 6.5 Research organizations and others - Market size and forecast 2023-2028
- 6.6 Market opportunity by End-user
7 Market Segmentation by Indication
- 7.1 Market segments
- 7.2 Comparison by Indication
- 7.3 AD - Market size and forecast 2023-2028
- 7.4 PD - Market size and forecast 2023-2028
- 7.5 ASD - Market size and forecast 2023-2028
- 7.6 MS - Market size and forecast 2023-2028
- 7.7 Others - Market size and forecast 2023-2028
- 7.8 Market opportunity by Indication
8 Customer Landscape
- 8.1 Customer landscape overview
9 Geographic Landscape
- 9.1 Geographic segmentation
- 9.2 Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- 9.4 Europe - Market size and forecast 2023-2028
- 9.5 Asia - Market size and forecast 2023-2028
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- 9.7 US - Market size and forecast 2023-2028
- 9.8 Germany - Market size and forecast 2023-2028
- 9.9 UK - Market size and forecast 2023-2028
- 9.10 China - Market size and forecast 2023-2028
- 9.11 France - Market size and forecast 2023-2028
- 9.12 Market opportunity By Geographical Landscape
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- 11.3 Landscape disruption
- 11.4 Industry risks
12 Vendor Analysis
- 12.1 Vendors covered
- 12.2 Market positioning of vendors
- 12.3 Abbott Laboratories
- 12.4 ACROBIOSYSTEMS INC.
- 12.5 Alseres Pharmaceuticals Inc
- 12.6 Bio Rad Laboratories Inc.
- 12.7 bioMerieux SA
- 12.8 Eli Lilly and Co.
- 12.9 F. Hoffmann La Roche Ltd.
- 12.10 IQVIA Holdings Inc.
- 12.11 Merck KGaA
- 12.12 Metabolon Inc.
- 12.13 PerkinElmer Inc
- 12.14 Proteome Sciences plc
- 12.15 QIAGEN NV
- 12.16 Quanterix Corp.
- 12.17 Thermo Fisher Scientific Inc.
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- 13.3 Currency conversion rates for US$
- 13.4 Research methodology
- 13.5 List of abbreviations
Product Code: IRTNTR73380
Exhibits:
- Exhibits1: Executive Summary - Chart on Market Overview
- Exhibits2: Executive Summary - Data Table on Market Overview
- Exhibits3: Executive Summary - Chart on Global Market Characteristics
- Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
- Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
- Exhibits6: Executive Summary - Chart on Market Segmentation by Indication
- Exhibits7: Executive Summary - Chart on Incremental Growth
- Exhibits8: Executive Summary - Data Table on Incremental Growth
- Exhibits9: Executive Summary - Chart on Vendor Market Positioning
- Exhibits10: Parent market
- Exhibits11: Market Characteristics
- Exhibits12: Offerings of vendors included in the market definition
- Exhibits13: Market segments
- Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits18: Historic Market Size - Data Table on global neurological biomarkers market 2018 - 2022 ($ billion)
- Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
- Exhibits20: Historic Market Size - Indication Segment 2018 - 2022 ($ billion)
- Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
- Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
- Exhibits23: Five forces analysis - Comparison between 2023 and 2028
- Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
- Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
- Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
- Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
- Exhibits29: Chart on Market condition - Five forces 2023 and 2028
- Exhibits30: Chart on End-user - Market share 2023-2028 (%)
- Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
- Exhibits32: Chart on Comparison by End-user
- Exhibits33: Data Table on Comparison by End-user
- Exhibits34: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
- Exhibits35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
- Exhibits36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
- Exhibits37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
- Exhibits38: Chart on Clinical diagnostic centers - Market size and forecast 2023-2028 ($ billion)
- Exhibits39: Data Table on Clinical diagnostic centers - Market size and forecast 2023-2028 ($ billion)
- Exhibits40: Chart on Clinical diagnostic centers - Year-over-year growth 2023-2028 (%)
- Exhibits41: Data Table on Clinical diagnostic centers - Year-over-year growth 2023-2028 (%)
- Exhibits42: Chart on Research organizations and others - Market size and forecast 2023-2028 ($ billion)
- Exhibits43: Data Table on Research organizations and others - Market size and forecast 2023-2028 ($ billion)
- Exhibits44: Chart on Research organizations and others - Year-over-year growth 2023-2028 (%)
- Exhibits45: Data Table on Research organizations and others - Year-over-year growth 2023-2028 (%)
- Exhibits46: Market opportunity by End-user ($ billion)
- Exhibits47: Data Table on Market opportunity by End-user ($ billion)
- Exhibits48: Chart on Indication - Market share 2023-2028 (%)
- Exhibits49: Data Table on Indication - Market share 2023-2028 (%)
- Exhibits50: Chart on Comparison by Indication
- Exhibits51: Data Table on Comparison by Indication
- Exhibits52: Chart on AD - Market size and forecast 2023-2028 ($ billion)
- Exhibits53: Data Table on AD - Market size and forecast 2023-2028 ($ billion)
- Exhibits54: Chart on AD - Year-over-year growth 2023-2028 (%)
- Exhibits55: Data Table on AD - Year-over-year growth 2023-2028 (%)
- Exhibits56: Chart on PD - Market size and forecast 2023-2028 ($ billion)
- Exhibits57: Data Table on PD - Market size and forecast 2023-2028 ($ billion)
- Exhibits58: Chart on PD - Year-over-year growth 2023-2028 (%)
- Exhibits59: Data Table on PD - Year-over-year growth 2023-2028 (%)
- Exhibits60: Chart on ASD - Market size and forecast 2023-2028 ($ billion)
- Exhibits61: Data Table on ASD - Market size and forecast 2023-2028 ($ billion)
- Exhibits62: Chart on ASD - Year-over-year growth 2023-2028 (%)
- Exhibits63: Data Table on ASD - Year-over-year growth 2023-2028 (%)
- Exhibits64: Chart on MS - Market size and forecast 2023-2028 ($ billion)
- Exhibits65: Data Table on MS - Market size and forecast 2023-2028 ($ billion)
- Exhibits66: Chart on MS - Year-over-year growth 2023-2028 (%)
- Exhibits67: Data Table on MS - Year-over-year growth 2023-2028 (%)
- Exhibits68: Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibits69: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibits70: Chart on Others - Year-over-year growth 2023-2028 (%)
- Exhibits71: Data Table on Others - Year-over-year growth 2023-2028 (%)
- Exhibits72: Market opportunity by Indication ($ billion)
- Exhibits73: Data Table on Market opportunity by Indication ($ billion)
- Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Exhibits75: Chart on Market share By Geographical Landscape 2023-2028 (%)
- Exhibits76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
- Exhibits77: Chart on Geographic comparison
- Exhibits78: Data Table on Geographic comparison
- Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%)
- Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibits88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibits89: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits95: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibits96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibits97: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibits98: Data Table on US - Year-over-year growth 2023-2028 (%)
- Exhibits99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibits100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibits101: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibits102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%)
- Exhibits107: Chart on China - Market size and forecast 2023-2028 ($ billion)
- Exhibits108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Exhibits109: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibits110: Data Table on China - Year-over-year growth 2023-2028 (%)
- Exhibits111: Chart on France - Market size and forecast 2023-2028 ($ billion)
- Exhibits112: Data Table on France - Market size and forecast 2023-2028 ($ billion)
- Exhibits113: Chart on France - Year-over-year growth 2023-2028 (%)
- Exhibits114: Data Table on France - Year-over-year growth 2023-2028 (%)
- Exhibits115: Market opportunity By Geographical Landscape ($ billion)
- Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
- Exhibits117: Impact of drivers and challenges in 2023 and 2028
- Exhibits118: Overview on Criticality of inputs and Factors of differentiation
- Exhibits119: Overview on factors of disruption
- Exhibits120: Impact of key risks on business
- Exhibits121: Vendors covered
- Exhibits122: Matrix on vendor position and classification
- Exhibits123: Abbott Laboratories - Overview
- Exhibits124: Abbott Laboratories - Business segments
- Exhibits125: Abbott Laboratories - Key news
- Exhibits126: Abbott Laboratories - Key offerings
- Exhibits127: Abbott Laboratories - Segment focus
- Exhibits128: ACROBIOSYSTEMS INC. - Overview
- Exhibits129: ACROBIOSYSTEMS INC. - Product / Service
- Exhibits130: ACROBIOSYSTEMS INC. - Key offerings
- Exhibits131: Alseres Pharmaceuticals Inc - Overview
- Exhibits132: Alseres Pharmaceuticals Inc - Product / Service
- Exhibits133: Alseres Pharmaceuticals Inc - Key offerings
- Exhibits134: Bio Rad Laboratories Inc. - Overview
- Exhibits135: Bio Rad Laboratories Inc. - Business segments
- Exhibits136: Bio Rad Laboratories Inc. - Key news
- Exhibits137: Bio Rad Laboratories Inc. - Key offerings
- Exhibits138: Bio Rad Laboratories Inc. - Segment focus
- Exhibits139: bioMerieux SA - Overview
- Exhibits140: bioMerieux SA - Product / Service
- Exhibits141: bioMerieux SA - Key news
- Exhibits142: bioMerieux SA - Key offerings
- Exhibits143: Eli Lilly and Co. - Overview
- Exhibits144: Eli Lilly and Co. - Product / Service
- Exhibits145: Eli Lilly and Co. - Key news
- Exhibits146: Eli Lilly and Co. - Key offerings
- Exhibits147: F. Hoffmann La Roche Ltd. - Overview
- Exhibits148: F. Hoffmann La Roche Ltd. - Business segments
- Exhibits149: F. Hoffmann La Roche Ltd. - Key news
- Exhibits150: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibits151: F. Hoffmann La Roche Ltd. - Segment focus
- Exhibits152: IQVIA Holdings Inc. - Overview
- Exhibits153: IQVIA Holdings Inc. - Business segments
- Exhibits154: IQVIA Holdings Inc. - Key news
- Exhibits155: IQVIA Holdings Inc. - Key offerings
- Exhibits156: IQVIA Holdings Inc. - Segment focus
- Exhibits157: Merck KGaA - Overview
- Exhibits158: Merck KGaA - Business segments
- Exhibits159: Merck KGaA - Key news
- Exhibits160: Merck KGaA - Key offerings
- Exhibits161: Merck KGaA - Segment focus
- Exhibits162: Metabolon Inc. - Overview
- Exhibits163: Metabolon Inc. - Product / Service
- Exhibits164: Metabolon Inc. - Key offerings
- Exhibits165: PerkinElmer Inc - Overview
- Exhibits166: PerkinElmer Inc - Business segments
- Exhibits167: PerkinElmer Inc - Key news
- Exhibits168: PerkinElmer Inc - Key offerings
- Exhibits169: PerkinElmer Inc - Segment focus
- Exhibits170: Proteome Sciences plc - Overview
- Exhibits171: Proteome Sciences plc - Product / Service
- Exhibits172: Proteome Sciences plc - Key offerings
- Exhibits173: QIAGEN NV - Overview
- Exhibits174: QIAGEN NV - Product / Service
- Exhibits175: QIAGEN NV - Key news
- Exhibits176: QIAGEN NV - Key offerings
- Exhibits177: Quanterix Corp. - Overview
- Exhibits178: Quanterix Corp. - Product / Service
- Exhibits179: Quanterix Corp. - Key offerings
- Exhibits180: Thermo Fisher Scientific Inc. - Overview
- Exhibits181: Thermo Fisher Scientific Inc. - Business segments
- Exhibits182: Thermo Fisher Scientific Inc. - Key news
- Exhibits183: Thermo Fisher Scientific Inc. - Key offerings
- Exhibits184: Thermo Fisher Scientific Inc. - Segment focus
- Exhibits185: Inclusions checklist
- Exhibits186: Exclusions checklist
- Exhibits187: Currency conversion rates for US$
- Exhibits188: Research methodology
- Exhibits189: Validation techniques employed for market sizing
- Exhibits190: Information sources
- Exhibits191: List of abbreviations
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.